Last updated: about 2 months ago
Vertex Pharmaceuticals Q1 2025 Financial Report: Revenue Growth Amid Profit Decline
Explore Vertex Pharmaceuticals' Q1 2025 financial insights, revealing strong revenue growth but significant net income decline. Recommendations suggest holding stock amid rising expenses.